Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Gynaecomastia secondary to transdermal oestradiol used for androgen deprivation therapy: informed reality vs subjective fear.
Journal: BJU international
Published: July 14, 2026
Letter: Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population.
Journal: Urology practice
Published: February 23, 2026
Letter: Shared Decision-Making in Prostate Cancer Management: Easy to Say, Hard to Measure.
Journal: The Journal of urology
Published: February 09, 2026
Comment on: 'Preferences between three options for androgen deprivation therapy…'.
Journal: BJU international
Published: November 14, 2025
Re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7.
Journal: European urology
Published: January 25, 2024
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: November 18, 2019
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.
Journal: Prostate cancer and prostatic diseases
Published: October 30, 2019
Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens.
Journal: The Journal of urology
Published: April 17, 2018
Oestrogen redux: will transdermal delivery rebalance the risk-benefit equation?
Journal: BJU international
Published: April 11, 2017
A Urologist's Personal View of Prostate Cancer.
Journal: Turkish journal of urology
Published: September 17, 2016
Last Updated: 09/26/2026